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Background
Headaches are a well known feature of Mitochondrial
Disorders (MCDs). However, no systematic epidemiolo-
gical data are available in large populations of patients.
We aimed to describe the prevalence and the charac-
teristics of headache in a large group of patients with
mitochondrial encephalomyopathies.
Methods
We studied all consecutive patients referred to our
Neuromuscular Unit, during a 6-month period. Ninety-
three patients (aged 15 to 78 years, 31 males) with a
typical phenotype of MCDs, underwent a structured
diagnostic headache interview, using an operational
diagnostic tool following the IHS criteria. If they met
the criteria for primary headache, they were included
in the “Headache Group” (HEAD+). The other patients
were collected in the “No Headache Group” (HEAD-).
Clinical, neuroradiological, and neurophysiological data
were compared between groups. Mann-Whitney U-test
was used to analyze numeric variables; Fisher’s exact
test was used to analyze nominal variables. Binary
logistic regression analysis was performed to identify
risk factors of headache.
Results
Headaches were reported in 35.48% of patients. Migraine
was the most common headache. The patients of
the Headache Group were younger (HEAD+ = 45.5±
17.2 years; HEAD- = 54.5±14.8 years; U-test = 7.393;
p = 0.007), increased prevalence of epilepsy (p = 0.0103),
myoclonus (p = 0.0309), stroke (p = 0.0290), EEG focal
slow abnormalities (p = 0.0359), EEG epileptic focal
abnormalities (p = 0.0425), and decreased prevalence of
muscle weakness (p < 0.0001) and EEG normal pattern
(p = 0.0136). Multivariate analysis showed that HEAD+
was significantly associated with absence of muscle weak-
ness (CI = 1.007-14.894; p = 0.049) and EEG abnormalities
(CI = 1.347-78.085; p = 0.025).
Conclusions
Migraine has a higher prevalence in MCDs compared to
population-based data. Our findings are consistent with
the widely hypothesized role of mitochondria in the
migraine pathophysiology.
Written informed consent to publication was obtained
from the patient(s).
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